MiR-22 suppresses the growth and metastasis of bladder cancer cells by targeting E2F3.

In conclusion, miR-22 suppressed cell proliferation, migration, invasion, and EMT in bladder cancer cells by regulating E2F3 expression, providing a novel avenue for treatment of bladder cancer.
PMID: 32269700 [PubMed]

Source: International Journal of Clinical and Experimental Pathology - April 10, 2020 Category: Pathology Authors: Guo J, Zhang J, Yang T, Zhang W, Liu M Tags: Int J Clin Exp Pathol Source Type: research